Mylan NV must continue to defend against litigation accusing it of colluding to inflate the price of life-saving EpiPen ...

Mylan has finalised an agreement to pay the US government $465 million, resolving a case accusing the pharma company of overcharging for its EpiPen anti-allergy pen. EpiPens provide a potentially ...

Governor Kathy Hochul on Thursday signed legislation that will reduce the costs of epinephrine auto-injector ("EpiPen") ...

Mylan is expanding a previously announced overseas recall to now include EpiPen and EpiPen Jr. devices distributed in the U.S. over concerns they may not function properly when needed. Like the ...

The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...

The pivot came amid pressure to cut the price of the drug that's up 500% since Mylan acquired it in 2007. "The system is broken. Look, first and foremost we want everyone with an EpiPen to have one.

Mylan, the drugmaker feeling the heat over its pricing of the EpiPen, said Monday that it will make an "authorized generic" version of the EpiPen that will cost $300 for a two-pack. It will also ...

Sanofi claims its Auvi-Q, a more portable epinephrine autoinjector with a retractable needle and audio instructions, couldn't compete on the unlevel playing field Mylan created for its EpiPen. (CN) — ...

The 10th Circuit Court of Appeals said that the exclusivity deals struck between the maker of EpiPen and insurance companies didn't shut out competition and were in consumers' best interest. (CN) — ...

Members of the Senate Finance Committee have questions about EpiPen-maker Mylan's relationship with Medicaid. They just sent a letter to Daniel Levinson, the Inspector General of the US Department ...

Here Krugman explains the real issues behind the EpiPen price hike. Follow BI Video: On Twitter More from Science Paul Krugman stopped by Business Insider to talk to senior editor Josh Barro.